Peripheral neuropathy is one of the rarely reported neurological complicati
ons of interferon therapy. The authors report such a case in a 15-year-old
boy during alpha-interferon therapy for Hodgkin's disease. He received alph
a-interferon at a dose of 1.8 million units/day 5 times a week by subcutane
ous injections as adjuvant immunotherapy post autologous stem cell transpla
nt. Twenty months after the initiation of therapy, he complained of severe
pain in his lower distal extremities. Neurological examination revealed the
absence of deep tendon reflexes. A nerve conduction study showed a sensori
al, polyneuropathic involvement in the lower extremities. Within 4 weeks af
ter the stopping of interferon, his pain Improved, and recovery was also se
en by nerve conduction studies. Symptoms reappeared at the resumption of in
terferon treatment. This study suggests that peripheral neuropathy may rare
ly occur in patients given long-term interferon treatment at high cumulativ
e dosage.